A B S T R A C T The physiological role of thyrotropinreleasing hormone (TRH) in the regulation of thyrotropin (thyroid-stimulating hormone, TSH) and prolactin (Prl) secretion has been assumed but not proven. Stimulation of their release requires pharmacologic doses of TRH. Lesions of the hypothalamus usually induce an inhibition of TSH secretion and an increase in Prl. To determine whether TRH is essential for TSH and Prl secretion in the rat, 0.1 ml of TRH antiserum (TRH-Ab) or normal rabbit serum was administered to normal, thyroidectomized, cold-exposed, and proestrus rats through indwelling atrial catheter. Serum samples were obtained before and at frequent intervals thereafter. Serum TSH concentrations in normal, thyroidectomized, cold-exposed, and proestrus rats were not depressed in specimens obtained up to 24 h after injection of normal rabbit serum. In contrast, serum TSH was significantly decreased after the administration of TRH-Ab in all normal (basal, 41±8 AU/ml [mean±SE]; 30 min, 6+-2; 45 min, 8+3; 75 min, 4±2); thyroidectomized (basal, 642+32 ,uU/ml; 30 min, 418±32; 60 min, 426±36; 120 min, 516±146); coldstressed (basal, 68±19 uU/ml; 30 min, 4±3; 180 min, 16±8); and proestrus (basal, 11 a.m., 57±10,U/ml; 1 p.m., 20±3; 3 p.m., 13±4; 5 p.m., 19±3) rats. However, 0.1 ml of TRH-Ab had no effect on basal Prl concentrations in normal or thyroidectomized rats and did not prevent the Prl rise in rats exposed to cold (basal, 68+7 ng/ml; 15 min, 387±121; 30 min, 212+ 132; 60 min, 154+114), or the Prl surge observed on the afternoon of proestrus (basal 11 a.m., 23±2 ng/ml; 1 p.m., 189±55; 3 p.m., 1,490±260; 5 p.m., 1,570+286). These studies demonstrate that TRH is required for TSH secretion in the normal, cold-exposed and proestrus rat and contributes, at least in part, to TSH secretion in the hypothyroid rat, but is not required for Prl secretion in these states.
A B S T R A C T The physiological role of thyrotropinreleasing hormone (TRH) in the regulation of thyrotropin (thyroid-stimulating hormone, TSH) and prolactin (Prl) secretion has been assumed but not proven. Stimulation of their release requires pharmacologic doses of TRH. Lesions of the hypothalamus usually induce an inhibition of TSH secretion and an increase in Prl. To determine whether TRH is essential for TSH and Prl secretion in the rat, 0.1 ml of TRH antiserum (TRH-Ab) or normal rabbit serum was administered to normal, thyroidectomized, cold-exposed, and proestrus rats through indwelling atrial catheter. Serum samples were obtained before and at frequent intervals thereafter. Serum TSH concentrations in normal, thyroidectomized, cold-exposed, and proestrus rats were not depressed in specimens obtained up to 24 h after injection of normal rabbit serum. In contrast, serum TSH was significantly decreased after the administration of TRH-Ab in all normal (basal, 41±8 AU/ml [mean±SE] ; 30 min, 6+-2; 45 min, 8+3; 75 min, 4±2); thyroidectomized (basal, 642+32 ,uU/ml; 30 min, 418±32; 60 min, 426±36; 120 min, 516±146); coldstressed (basal, 68±19 uU/ml; 30 min, 4±3; 180 min, 16±8); and proestrus (basal, 11 a.m., 57±10,U/ml; 1 p.m., 20±3; 3 p.m., 13±4; 5 p.m., 19±3) rats. However, 0.1 ml of TRH-Ab had no effect on basal Prl concentrations in normal or thyroidectomized rats and did not prevent the Prl rise in rats exposed to cold INTRODUCTION The administration of pharmacologic doses of thyrotropin-releasing hormone (TRH)' has been demonstrated to stimulate thyrotropin (thyroid-stimulating hormone, TSH) and prolactin (Prl) synthesis and release from the anterior pituitary (1) (2) (3) (4) (5) . Surgical or pathologic lesions ofthe hypothalamus have resulted in decreased TSH release and subsequent hypothyroidism (6) (7) (8) (9) (10) . It is well established that Prl secretion is tonically suppressed by dopamine either by a direct effect on the pituitary or by modulating the release of the Prl inhibiting factor. Median eminence and pituitary stalk lesions usually enhance rather than suppress Prl secretion (11, 12) , although this is not always observed in unstressed rats after hypothalamic deafferentation (13) . In intact animals, electrical stimulation of the hypothalamic "hypophysiotropic area" (14) has been shown to increase serum TSH levels (10, 15) , presumably secondary to TRH release, although direct experimental evidence of enhanced TRH release is lacking. The effect of such electrical stimulation on Prl secretion is variable (16 (17, 18) , but breast-feeding in man is associated with normal serum TSH and increased Prl concentrations (19) . A concomitant increase in the serum concentrations ofTSH and Prl has been reported in some patients with primary hypothyroidism (20) (21) (22) (23) (24) and in rats exposed to the cold (25, 26) .
To clarify the physiological role of TRH on TSH and Prl secretion, a nontoxic substance that selectively inactivates TRH in vivo could be employed. Recently, specific antisera have been administered in vivo to bind somatostatin (27) (28) (29) , luteinizing hormone releasing hormone (30) (31) (32) , and TRH (33) . This study reports the effect of a specific TRH antibody administered to normal, thyroidectomized, proestrus, and cold-exposed rats on the serum concentrations of TSH and Prl measured by radioimmunoassay (RIA), and on the biological activity of TSH as assessed by thyroid function. 24 h later in one experiment and at 30 and 120 min in another. Volume was replaced with normal saline. Blood was quickly spun, serum separated, and stored at -20°C until assayed for Prl, TSH, T3, and thyroxine (T4).
METHODS
Iodine-deficient rats. The biological effect ofa decrease in serum TSH was assessed in the rat model as described by Greer et al. (36) , who observed that acute hypophysectomy in the iodine-deficient rat resulted in a paradoxical increase in thyroid 131I uptake due to an acute inhibition of 131I release secondary to a lack ofTSH. The effect ofacute changes in TSH was determined by measuring the release of 1311 from the prelabeled thyroid gland. Male rats were fed a low iodine diet containing 34 ,ug I/kg for 3 wk and atrial catheters inserted 24 h before the experiment. At 8 a.m., 1.0 ml blood was obtained through the catheter and either 0.5 ml TRH-Ab or NRS were administered i.v. through the catheter. 30 min later, 10 ACi 131I was given i.v. Rats were bled and sacrificed 2.5 or 5.5 h after 131I. Thyroids were quickly removed, weighed, and homogenized in 0.5 ml veronal buffer. Aliquots (50 ,ul ofa 1:20 dilution) of the thyroid homogenates and an appropriately diluted standard were counted in a gamma scintillation counter and the percent 131I retained in the thyroid determined. 0.3-ml aliquots of serum were diluted to 0.8 ml by addition of 0.5 ml normal human serum. Protein was precipitated with 0.3 ml of 20% trichloroacetic acid (TCA) and the precipitate washed twice with 2 ml of 5% TCA. The TCA precipitate was dissolved in 0.1 ml of 1 N NaOH, diluted to 3 ml with saline and counted to determine the serum TCA precipitable and presumably hormonal 1311. T3 concentration was measured in ethanol extracts of control sera and sera obtained at 3 and 6 h after TRH-Ab or NRS administration.
Hypothyroid rats. 5 days after thyroidectomy, rats were cannulated as described above. At 8 a.m. on the second day after cannulation, control serum was obtained and TRH-Ab or NRS then administered through the catheter. Blood specimens were obtained 30, 60, and 120 min and 24 h later.
In another series of experiments, atrial catheters were inserted 8 days after thyroidectomy and 1 day later blood was obtained through the catheter. TRH antibodies raised in four different rabbits or NRS were injected i.v. and blood obtained 30 min later. The titer of each TRH-Ab was determined by the final dilution required to bind 30-35% 121I-TRH in the in-vitro RIA for TRH.
Cold-exposed rats. Animals were prepared as described above. 15 min after the first blood sample was obtained, rats were injected with TRH-Ab or NRS. Single animals were then moved in their individual wire mesh cages to an adjacent cold room and exposed to 4± +1C for 60 min. Blood was obtained 10, 25 , and 60 min and 24 h later. In another experiment, rats were housed in a temperature-controlled environmental room at 25°C for 2 days. Temperature was then decreased to 15°C by 1 h and to 40C over the next 2 h. Approximately 15 min before lowering the temperature, blood was withdrawn through the catheter and TRH-Ab given i.v. Blood was obtained at 1 h (15°C) and 3 h (4'C) later.
Proestrus rats. Cycling female rats were studied at proestrus after two consecutive 4-day cycles determined by vaginal smear cytology. Aortic cannulation was performed between 7 p.m. and 10 p.m. on the evening of diestrus 2 and catheters flushed with heparinized saline (16 U/dl normal saline).
On the day of proestrus, blood was obtained at 11 a.m. The rats were then injected with TRH-Ab or NRS at 12:30 a.m. Blood samples were obtained at 1 p.m., 3 p.m., and 5 p.m. After separation, the plasma was stored at -20°C until assayed for Prl, leuteinizing hormone, and TSH. On the day of estrus, the animals were sacrificed and autopsied to ascertain whether ovulation had occurred. Only rats that had ovulated were included in the final results.
Hormone measurements. Double antibody radioimmunoassays of Prl, TSH, and leuteinizing hormone were carried out with National Institute of Arthritis and Metabolic Diseases (National Institutes of Health) kits, using anti-rabbit goat y-globulin as a second antibody. Serum T4 concentration was measured by the Corning Solid Phase RIA kit (Corning Medical, Corning Glass Works, Medfield, MA). Serum T3 concentration was measured by RIA as described (37) . All specimens from individual experiments were measured in duplicate in the same assay. Statistical analysis was carried out by unpaired Student's t or paired t test (38) .
RESULTS
Effect of TRH-Ab on serum TSH and Prl concentrations, and thyroid function in the normal rat. The administration of TRH-Ab strikingly decreased the mean serum TSH concentration from a control value of 135+25 ,tU/ml (mean+SE) to 57+9 at 30 min and to 45+8 at 2 h (Table I ). In contrast, NRS did not affect the serum TSH concentration. The mean serum Prl concentration was unaffected by either TRH-Ab or NRS. In another experiment, TRH-Ab again decreased serum TSH from a control valuie of 41.4+8 ,uU/ml to almost undetectable levels at 30 min. The mean serum TSH concentration remained essentially undetectable for at least 75 min and returned to control values at 24 h (35+5 AU/ml). In contrast, NRS did not affect the mean serum TSH concentration. The decrease in serum TSH concentration resulted in a progressively significant decrease in serum T3 concentration in rats treated with TRH-Ab, whereas NRS had no effect (Fig. 1) . Serum T4 concentration remained unchanged in both groups.
In iodine-deficient rats (Fig. 2) , the 2.5 h thyroid 1311 uptake was slightly increased in animals receiving TRH-Ab as compared to those given NRS (39.6± 1.6 vs. 35 .2±+2.8%; NS) and at 5.5 h, this increase was significant (42.5+3.0 vs. 34.0+1.5%; P < 0.05). The serum TCA precipitable 1311 was decreased in TRH-Ab rats at 2.5 h (526+38 vs. 1,045±+187 cpm/ml; P < 0.05) and strikingly decreased at 5.5 h (510+45 vs. 3,896+811 cpm/ml; P < 0.005). T3 concentrations in ethanol extracts of serum were significantly decreased 3 h (115+11 vs. 81+7 ng/dl; paired t test, P < 0.005) and 6 h (112±7 vs. 58±5 ng/dl; paired t test, P < 0.001) after TRH-Ab administration. In contrast, the mean serum T3 concentration was unchanged in rats given NRS (3 h, 111±3 vs. 96±6 ng/dl; 6 h, 106±9 vs. 112±5 ng/dl).
Effect of TRH-Ab on serum TSH and Prl concentration in the hypothyroid rat. The administration of TRH-Ab significantly decreased the elevated basal serum TSH concentration (640±32 ,uU/ml) at 30 min (420+33 uU/ml; P < 0.001), and 60 min (425+37 ,uU/ml; P < 0.001), but not at 120 min or 24 h. NRS did not significantly lower the mean serum TSH concentration in these hypothyroid rats. Serum Prl concentrations FIGURE 2 Effect of TRH-Ab on the thyroid 1311 uptake and serum TCA precipitable 131I in iodine-deficient (34 ,g I/kg for 3 wk) male rats. 30 min after TRH-Ab (0.5 ml i.v.) or NRS (0.5 ml i.v.), 10,tCi 1311 was given i.v. and rats bled and sacrificed 2.5 or 5.5 h later. Rats given TRH-Ab 6 h earlier retained a significantly higher percentage of administered 1311 in the thyroid as compared to animals given NRS and also had markedly diminished serum TCA precipitable 1311 at 3 and 6 h after injection of antisera. were similar in rats receiving TRH-Ab or NRS (Table  II) . In another experiment, the suppressive effect of TRH-Ab on serum TSH persisted for 2 h (basal 1,012+71 vs. 2 h, 696±112; student's t test, P < 0.05).
To exclude the possibility that the decrease in serum TSH after TRH-Ab in the hypothyroid rat was due to hyperimmune rabbit serum per se, various TRH antisera were administered to groups of hypothyroid rats (Fig. 3) . As was observed with NRS, low potency TRH-Ab (1:4,000) did not decrease serum TSH concentration at 30 min. In contrast, high potency TRH-Abs significantly decreased serum TSH concentration 30 min after their administration. The greatest inhibition was induced by the most potent antibody (1:50,000), resulting in a 65% decrease at 30 min. The decrease in the mean serum TSH concentration persisted for at least 60 min in the rats receiving the three most potent antibodies.
Effect of TRH-Ab on the cold-induced increase in serum TSH and Prl concentrations. Exposure of rats to 40C for 3 h resulted in a highly significant increase in serum TSH concentration (59±+12 vs. 147+15; paired t test, P < 0.001) (Fig. 4) . The administration of TRH-Ab before cold exposure not only prevented the coldinduced rise in serum TSH but decreased serum TSH to undetectable or very low values. In another experiment (Table III) , short-term (60 min) exposure of rats to the cold (4°C) markedly increased the serum Prl concentration. TRH-Ab did not prevent this cold-induced rise in serum Prl concentration.
Effect of TRH-Ab on the serum Prl surge in the proestrus rat. The administration of TRH-Ab or NRS at 12:30 p.m. did not prevent the afternoon Prl or LH surge (Table IV) . At 3 p.m., serum Prl was significantly higher in rats receiving TRH-Ab (P < 0.05). In these 
DISCUSSION
The administration of TRH-Ab to the normal rat induced a rapid decrease in the mean serum TSH concentrations within 30 min which persisted for 2 h, providing compelling evidence that, under physiologic conditions, secretion of TRH is re(quired to sustain TSH release from the pituitary. Also, the enhanced secretion of TSH after cold exposure was inhibited in rats pretreated with TRH-Ab. These findings indicate that the cold-induced rise in TSH secretion is mediated by TRH as suggested by others (25, 33, 39) . Several findings from the present study demonstrate that the decreased TSH secretion assessed by measurement of serum TSH by RIA was associated with decreased biological activity as well. First, the serum T3 concentration in normal rats decreased significantly after TRH-Ab administration. Moreover, in iodinedeficient rats, in which serum T3 is primarily derived from thyroid secretion rather than from peripheral conversion of T4 (40, 41) , administration of TRH-Ab resulted in a marked decrease in serum T3 concentration. A similar decrease in serum T3 has been seen after the administration of TSH-Ab (42) . Second, the TCA precipitable 1311, representing secreted 1311-T4 and T3, was dramatically decreased after TRH-Ab administration. Third, the thyroid 1311 uptake was higher in the TRH-Ab-treated rats as compared to control rats, indicating a rapid decrease in circulating TSH (36) .
The role of TRH in the secretion of TSH in hypothyroidism has been questioned. Hypothalamic lesioned, thyroidectomized rats exhibit a substantial rise in serum TSH, despite a probable reduction in portal blood TRH concentrations (10, 43) . Small doses of T4, insufficient to decrease the elevated serum TSH in the nonlesioned, thyroidectomized rats, were effective in suppressing TSH in the hypothalamic-lesioned, thyroidectomized animals, suggesting that, in the absence of TRH, the negative feedback of thyroid hormones at the pituitary is more pronounced. Furthermore, after completion of our studies, Mueller et al. (44) reported in abstract form that serum TSH was not decreased 2 h after TRH-Ab was administered to thyroidectomized rats. The present studies, however, suggest that TRH is at least partially responsible for sustained TSH secretion observed in primary hypothyroidism. Injection of four different TRH antisera to thyroidectomized rats resulted in a substantial decrease in serum TSH 30 and 60 min later, an effect that persisted for 2 h in one experiment. Another TRH antiserum with a weak titer (1:4,000) had no Thyrotropin-Releasing Hormone Antibody Blockade studies, the decrease in serum TSH persisted up to 2 h in only one experiment. Serum TRH has been reported to be similar in the normal and hypothyroid rat (39, 45) and the serum TRH degrading enzyme activity lower in hypothyroid man and rat (46, 47 (50) and rat pituitary cell cultures (51) . Furthermore, preliminary data suggest that both serum TSH and serum Prl concentrations rise during proestrus in the rat (52) . In the present study, however, the administration of TRH-Ab failed to decrease serum Prl in normal, proestrus, cold-exposed and hypothyroid rats even though serum TSH was strikingly decreased. It was also found that TRH-Ab did not decrease the proestrus luteinizing hormone surge.
Since completion of our study, Koch et al. (53) reported that 1 ml of TRH-Ab administered intraperitonealy resulted in a decrease in serum Prl in normal, diestrus, and proestrus rats. The explanation for the difference in the Prl response to TRH-Ab between their study and the present findings is not readily apparent. The large volume of sera used by these workers would have resulted in different quantities of y-globulin injection in TRH-Ab-treated, as compared to their NRS-treated control animals, and this may have interfered with the double antibody Prl RIA. Also, the different route ofTRH-Ab administration and the use of ether anesthesia to obtain blood by heart puncture may have influenced their results since diestrus Prl values were elevated, suggesting stress. Furthermore, in their proestrus experiment, only one serum sample was obtained at 3 p.m. and the Prl values were not sufficiently elevated to indicate peak proestrus levels. The proestrus prolactin surge may have been delayed in this group of antibody-treated rats irrespective of the treatment employed, because we have frequently observed delays in the Prl surge in proestrus rats.
The present study strongly suggests that endogenous TRH secretion is required for TSH secretion in the rat under a variety of circumstances. It is apparent, however, that endogenous TRH is probably not required for the physiologic control of Prl secretion. Whether these findings in the rat can be extrapolated to man remains to be investigated.
